View Post

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit

In In The News by Barbara Jacoby

From: www.nccn.org The National Comprehensive Cancer Network® (NCCN®) hosted a policy summit at the National Press Club in Washington, DC, today, addressing how to define, measure, and apply quality in cancer care. Speakers across the cancer care continuum shared perspectives on current quality measurement initiatives including the Oncology Care Model and the Merit-based Incentive Payment System (MIPS), and looked ahead …

View Post

Many Older Hospitalized Patients with Cancer Experience Malnutrition

In In The News by Barbara Jacoby

Source: Wiley Research News From: PR Newswire Results from a new study indicate that older hospitalized patients with cancer may have a high risk of being malnourished and experiencing symptoms such as no appetite and nausea, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society. Many individuals with cancer experience malnutrition, which can …

View Post

New York’s First Proton Therapy Center Begins Treating Patients

In In The News by Barbara Jacoby

From: PR Newswire The New York Proton Center, the first proton therapy facility to open in New York State, has begun treating patients. The center’s unique consortium of partners, comprised of three leading New York City health systems—Memorial Sloan Kettering Cancer Center (MSK), Montefiore Health System and Mount Sinai Health System—began sending patients to the state-of-the-art East Harlem facility in …

View Post

Importance of ER+ Patient Profiling to Determine MBC Therapy Options

In In The News by Barbara Jacoby

Source: AstraZeneca From: news-medical.net Cell receptors are special proteins found within and on the surface of certain cells that enable signals in the form of substances in the bloodstream to affect cell function. When a substance binds to the specific receptor designed to recognize it, the receptor will be activated, and a chain of events initiated to achieve the desired …

View Post

Dense Breasts 101: What You Need To Know if You Have This Type of Breast Tissue

In In The News by Barbara Jacoby

By: Barbara Brody From: everydayhealth.com If you have dense breast tissue, you’re at higher risk for breast cancer and your breasts will be harder to screen via mammograms. Here’s what you need to know to navigate risk and screening. Since the advent of the pink ribbon, women have been blasted with the message that mammograms save lives. And research does …

View Post

Breast cancer can form ‘sleeper cells’ after drug treatment

In In The News by Barbara Jacoby

Source: Imperial College London From: sciencedaily.com Breast cancer medicines may force some cancer cells into ‘sleeper mode’, allowing them to potentially come back to life years after initial treatment. These are the early-stage findings from scientists at Imperial College London, who studied human breast cancer cells in the laboratory. The team, who studied a group of breast cancer drugs called …

View Post

Modified Drug Combo May Improve Long-Term Outcomes for HER2-Negative Breast Cancer

In In The News by Barbara Jacoby

From: specialtypharmacytimes.com A modified drug combination may lead to a decreased chance of disease recurrence for women with high-risk, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, representing a potential for a shift in treatment protocol for an important subset of patients, according to an editorial published in the Journal of Clinical Oncology. For most women with lymph node …

View Post

FDA grants orphan drug designation to Nerlynx for breast cancer brain metastases

In In The News by Barbara Jacoby

Source: FDA News From: healio.com The FDA has granted neratinib orphan drug designation for the treatment of patients with breast cancer and brain metastases, according to a press release from the drug’s manufacturer. Neratinib (Nerlynx, Puma Biotechnology) — an irreversible pan-HER tyrosine kinase inhibitor — is approved for the extended adjuvant treatment of adults with HER2-overexpressed breast cancer, following adjuvant …

View Post

New guideline clarifies role of radiation therapy in pancreatic cancer treatment

In In The News by Barbara Jacoby

First-of-its-kind clinical guideline from leading radiation oncology society discusses radiation dosing, conventional versus stereotactic radiation and mitigating side effects A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to treat patients diagnosed with pancreatic cancer, including when radiation treatments are appropriate, as well as the optimal dosing, timing and …

View Post

New guidelines call for early breast cancer risk assessment

In In The News by Barbara Jacoby

By: Shayne Tarquinio From: azjewishpost.com Women should get a formal breast cancer risk assessment between the ages of 25 and 30, according to the new guidelines set by The American Society of Breast Surgeons (ASBrS), published in May. According to the organization, one in eight women, or 12 percent of women in the United States will be diagnosed with breast …